Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
ATRenew Inc. Q1 2026 Earnings Call - Record Profits Surge as 1P2C Retail Share Hits 45%
ATRenew Inc. delivered a quarter of stark contrast and clear direction, smashing revenue expectations while quietly repositioning its entire supply chain toward direct-to-consumer retail. Revenue jump...
- Revenue reached RMB 6.16 billion in Q1 2026, exceeding the high end of guidance and reflecting a 32.4% year-over-year increase.
- Non-GAAP operating profit surged 70.2% to over RMB 190 million, establishing a new record high for the company.
- The 1P2C retail share of product revenue climbed to 45.1%, up from 33% in the same period last year, signaling a decisive shift toward direct consumer sales.
- +9 more takeaways
Eltek Ltd Q1 2026 Earnings Call - Backlog Doubles Amid Supply Chain and FX Headwinds
Eltek reported a sharp earnings decline in Q1 2026, with revenues falling to $10.4 million from $12.8 million and a net loss of $2.9 million driven by a difficult product mix, persistent logistics bot...
- Q1 2026 revenues fell to $10.4 million, down from $12.8 million in Q1 2025, missing management expectations due to timing and mix issues.
- The company reported a net loss of $2.9 million ($0.42 per share) compared to a net income of $1 million in the prior year period.
- Gross margins were severely compressed, resulting in a $1.9 million gross loss due to deliveries from older, lower-priced backlog.
- +7 more takeaways
Gilat Satellite Networks Q1 2026 Earnings Call - Defense Momentum and IFC Growth Drive 20% Revenue Rise
Gilat Satellite Networks opened 2026 with a strong start, delivering $110.5 million in revenue, up 20% year-over-year, and nearly doubling Adjusted EBITDA to $15.1 million. The company’s diversified p...
- Revenue grew 20% year-over-year to $110.5 million, driven by strength across defense, commercial, and Peru segments.
- Adjusted EBITDA nearly doubled to $15.1 million, reflecting improved operating leverage and favorable deal mix.
- Defense segment saw significant traction in mobile SATCOM solutions, with a $16 million European order and $9 million Israeli contract.
- +7 more takeaways
Fractyl Health Q1 2026 Earnings Call - Pivotal Trial Execution and Capital Discipline Ahead of Q4 Data Readout
Fractyl Health delivered a quarter of disciplined execution, reinforcing its commitment to reaching pivotal data for Revita without a capital raise. The company completed randomization for its sham-co...
- Fractyl Health completed randomization for its pivotal REMAIN-1 trial in February, enrolling over 300 participants across 30 U.S. sites.
- The company reaffirmed its commitment to reaching pivotal data without a planned capital raise, with cash runway extending into early 2027.
- Revita's dose-response and patient selection data were highlighted as key drivers of efficacy, with stronger signals expected in patients with higher run-in weight loss and longer ablation lengths.
- +7 more takeaways
Hesai Group Q1 2026 Earnings Call - From LiDAR Leader to Spatial Intelligence Pioneer
Hesai Group delivered a strong Q1 2026, with revenue up 30% year-over-year to RMB 681 million and shipments exceeding 471,000 units. The company reaffirmed its full-year LiDAR shipment guidance of 3 t...
- Revenue surged 30% YoY to RMB 681 million, with LiDAR shipments exceeding 471,000 units in Q1 2026.
- Full-year shipment guidance raised to 3 to 3.5 million units, nearly doubling the record 1.6 million delivered in 2025.
- Backlog for LiDAR units now exceeds 6 million, driven by strong demand for the ATX platform and multi-lidar Level 3 architectures.
- +7 more takeaways
MakeMyTrip FY2026 Earnings Call - AI & Domestic Shift Offset Geopolitical Headwinds
MakeMyTrip delivered steady growth in FY2026 despite a volatile year marked by the West Asia conflict and rising fuel costs. The company's domestic business proved resilient, driven by a structural sh...
- Gross bookings reached a record $10.4 billion in FY2026, compounding at roughly 34% over four years, driven by post-pandemic recovery and structural shifts in Indian consumer behavior.
- Domestic travel remained resilient amid the West Asia conflict, with management shifting focus to eastbound international and domestic destinations to mitigate headwinds.
- AI is central to MakeMyTrip's strategy, with its conversational AI agent Myra handling over 80,000 conversations daily and driving a 10% higher conversion rate compared to traditional search journeys.
- +7 more takeaways
Antalpha Q1 2026 Earnings Call - Record 0 Loss Amid 52% Revenue Growth and Strategic Pivot to AI and Yield
Antalpha delivered a quarter of disciplined execution despite a brutal crypto market backdrop. Revenue surged 52% year-over-year to $20.7 million, driven by a resilient lending book that has maintaine...
- Revenue surged 52% year-over-year to $20.7 million, defying the broader crypto market downturn.
- Antalpha maintains a pristine record of zero principal losses since inception, validating its risk-first, overcollateralization model.
- Major borrower Canaan Inc. repaid approximately $530 million of its loan balance, reducing the total loan book by 3% but demonstrating borrower liquidity and credit health.
- +7 more takeaways
Relmada Therapeutics Q1 2026 Earnings Call - Secures $160M Financing and Advances NDV-01 Toward Mid-2026 Phase III Initiation
Relmada Therapeutics entered Q1 2026 with a fortified balance sheet and a clear path to Phase III. The company closed a $160 million private placement, lifting its cash position to $234 million and ex...
- Relmada closed a $160 million private placement in March 2026, increasing its cash balance to $234 million and providing sufficient runway to fund operations through 2029.
- The company remains on track to initiate the Phase III RESCUE registrational program for NDV-01 in mid-2026, following successful FDA alignment on the trial design.
- NDV-01 demonstrated a 76% complete response rate at 12 months in high-risk non-muscle invasive bladder cancer patients, with a durable 80% complete response rate in the BCG-unresponsive subgroup.
- +7 more takeaways
a.k.a. Brands Q1 2026 Earnings Call - Margin Expansion Signals Structural Turnaround
a.k.a. Brands delivered a Q1 2026 beat on net sales and Adjusted EBITDA, driven by a 180 basis point gross margin expansion that underscores the success of its multi-year inventory reset and test-and-...
- Net sales reached $132.5 million, up 3% year-over-year, and Adjusted EBITDA came in at $5.1 million, ahead of management expectations.
- Underlying gross margin expanded 180 basis points to 59%, driven by improved inventory discipline, stronger full-price sell-through, and the continued rollout of the test-and-repeat model, primarily within the streetwear brands.
- The company recognized a $25.8 million receivable from the reversal of IEEPA tariffs following the Supreme Court decision, though it also recorded a $12 million write-down on legacy streetwear inventory to align with its new buying model.
- +7 more takeaways
MicroVision Q1 2026 Earnings Call - Commercial Traction Returns After Luminar Integration
MicroVision's first quarter 2026 results mark a decisive pivot from experimental development to commercial execution. The company successfully integrated the Luminar and Scantinel acquisitions, consol...
- Revenue increased 50% year-over-year to $0.9 million, with 75% attributed to Luminar-acquired long-range sensors, signaling immediate commercial value from the acquisition.
- Gross margins surged to 39% in Q1, up from 7% in the prior year, with full-year guidance raised to 35%-40% as supply agreements are optimized.
- The company successfully integrated Luminar and Scantinel assets, consolidating all manufacturing into a single Orlando facility to streamline operations and reduce costs.
- +9 more takeaways